Study summary · research use only
Efficient production of l-glutathione by whole-cell catalysis with ATP regeneration from adenosine
Plain-language summary
Paraphrased from the published abstract below — not a verdict on whether anything works.
This study engineered Escherichia coli to improve production of l-glutathione (GSH), a tripeptide, via metabolic engineering of GSH biosynthesis genes combined with an adenosine-based ATP regeneration system (a whole-cell bacterial catalysis study, not an animal study). The authors report deleting genes linked to GSH and l-cysteine degradation and branched metabolic pathways, and overexpressing GSH bifunctional synthase (GshFSA) and the GSH exporter CydDC. The engineered strain, GSH17-FDC, achieved a GSH titer of 24.19 g/L after a 2 h reaction, with a conversion rate from added l-Cys reported at 98.39%.
Abstract
l-glutathione (GSH) is an important tripeptide compound with extensive applications in medicine, food additives, and cosmetics industries. In this work, an innovative whole-cell catalytic strategy was developed to enhance GSH production by combining metabolic engineering of GSH biosynthetic pathways with an adenosine-based adenosine triphosphate (ATP) regeneration system in Escherichia coli. Concretely, to enhance GSH production in E. coli, several genes associated with GSH and l-cysteine degradation, as well as the branched metabolic flow, were deleted. Additionally, the GSH bifunctional synthase (GshFSA) and GSH ATP-binding cassette exporter (CydDC) were overexpressed. Moreover, an adenosine-based ATP regeneration system was first introduced into E. coli to enhance GSH biosynthesis without exogenous ATP additions. Through the optimization of whole-cell catalytic conditions, the engineered strain GSH17-FDC achieved an impressive GSH titer of 24.19 g/L only after 2 h reaction, with a nearly 100% (98.39%) conversion rate from the added l-Cys. This work not only unveils a new platform for GSH production but also provides valuable insights for the production of other high-value metabolites that rely on ATP consumption.
pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.